Home > Analytics > HEALTHCARE GLOBAL ENTERPRISES

HEALTHCARE GLOBAL ENTERPRISES
Intrinsic Value | Fundamental Analysis

BOM : 539787     NSE : HCG    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Jun 24,2022
Price(EOD): β‚Ή 296.75
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Miscellaneous
MCap: β‚Ή 4,124.83 Cr
Value of β‚Ή 1 Lac invested in HEALTHCARE GLOBAL ENTERPRISES
on Jun 27,2017 (price: β‚Ή 244.05)

β‚Ή 1 L

β‚Ή 1.22 L

1W : 10.5% 1M : 7.1% 1Y : 44.2%
COMMUNITY POLL
for HEALTHCARE GLOBAL ENTERPRISES
Please provide your vote to see the results
HEALTHCARE GLOBAL ENTERPRISES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
HEALTHCARE GLOBAL ENTERPRISES 10.5% 7.1% 44.2%
SYNGENE INTERNATIONAL 5.4% 7.7% -5.5%
QUESS CORP -2.7% -6.7% -25.6%
SUN PHARMA ADVANCED RESEARCH COMPANY 17% -4.6% -19.3%
TEAMLEASE SERVICES -1.1% -6.2% -16.9%
SECURITY AND INTELLIGENCE SERVICES INDIA -0.4% -6.9% 4.4%
JUST DIAL 6.2% -15.5% -46.5%
DELTA CORP -1.9% -20.2% -4.6%
VA TECH WABAG -0.6% -0.5% -35.3%

FUNDAMENTAL ANALYSIS OF HEALTHCARE GLOBAL ENTERPRISES

 
Fundamentals Score
[ Q(TTM): Mar2022, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF HEALTHCARE GLOBAL ENTERPRISES

 
Valuation Score
[As on : Jun 24,2022 ]

Ratio Consolidated
P/E
P/B
P/S
-
P/E Calculated based on EPS of -15.43
[ Mar2021 - Consolidated Results ]

5.75
P/B Calculated based on Book Value of 51.57
[ Mar2021 - Consolidated Results ]

2.95
P/S Calculated based on Revenues of 1397.79 Cr
[ TTM - Consolidated Results ]

Financial Ratios →

Insights πŸ’‘ There are potential 23% undervalued companies ! Discover More →

FAIR VALUE OF HEALTHCARE GLOBAL ENTERPRISES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
34%
4%
0%

Insights πŸ’‘ You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF HEALTHCARE GLOBAL ENTERPRISES


Insights πŸ’‘ HCG is one of the top 10% companies with bullish price momentum currently! Discover More →

HEALTHCARE GLOBAL ENTERPRISES vs SENSEX


Insights πŸ’‘ You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF HEALTHCARE GLOBAL ENTERPRISES

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0.27
0.8
0.66
0.58
0.73
1.91
1.4
1.35
[Last Annual Data : Mar2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF HEALTHCARE GLOBAL ENTERPRISES

Pledged Promoter Shares
3 %
As on : Mar2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF HEALTHCARE GLOBAL ENTERPRISES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
1.83%
2.09%
101.99%
104.52%
22.34%
60.44%
100.87%
101.96%
QtrlyTrend
8
Latest Qtr: Mar2022
Quarterly Result Analysis →


HEALTHCARE GLOBAL ENTERPRISES related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 3.1% -1.8% -13%
S&P BSE ALLCAP 2.5% -2% -0.8%
S&P BSE MIDSMALLCAP 2% -1.4% -2%
S&P BSE SMALL CAP 1.6% -2.4% -1.3%
No NSE index found

You may also like the below Video Courses


FAQ about HEALTHCARE GLOBAL ENTERPRISES


Is HEALTHCARE GLOBAL ENTERPRISES good for long term investment?

As on Jun 24,2022, the Fundamentals of HEALTHCARE GLOBAL ENTERPRISES look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of HEALTHCARE GLOBAL ENTERPRISES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is HEALTHCARE GLOBAL ENTERPRISES UnderValued or OverValued?

As on Jun 24,2022, HEALTHCARE GLOBAL ENTERPRISES is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of HEALTHCARE GLOBAL ENTERPRISES ?

As on Jun 24,2022, the Intrinsic Value of HEALTHCARE GLOBAL ENTERPRISES is Rs. 286.09 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 222.23
Fair Value [Median EV / Sales Model] : Rs. 286.09
Fair Value [Median Price / Sales Model] : Rs. 296.05
Median Fair Value of HEALTHCARE GLOBAL ENTERPRISES : Rs. 286.09

Is HEALTHCARE GLOBAL ENTERPRISES trading at a Premium or Discount?

As on Jun 24,2022, HEALTHCARE GLOBAL ENTERPRISES is trading at a Premium of 4% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z